Detalles de la búsqueda
1.
Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition.
Mol Psychiatry
; 29(4): 992-1004, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38216727
2.
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings.
Alzheimers Dement
; 20(4): 2340-2352, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38284555
3.
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
Brain
; 145(7): 2507-2517, 2022 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35088840
4.
Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment.
J Nanobiotechnology
; 21(1): 54, 2023 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788617
5.
Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults.
Int J Mol Sci
; 24(3)2023 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36768512
6.
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment.
Int J Mol Sci
; 24(2)2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674881
7.
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
Alzheimers Dement
; 18(10): 1868-1879, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936194
8.
Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort.
Int J Mol Sci
; 23(13)2022 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35805894
9.
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
PLoS Med
; 17(8): e1003289, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32817639
10.
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.
Acta Neuropathol
; 139(6): 1025-1044, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32166339
11.
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Acta Neuropathol
; 139(5): 959-962, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31955222
12.
Novel Inhaled Pan-JAK Inhibitor, LAS194046, Reduces Allergen-Induced Airway Inflammation, Late Asthmatic Response, and pSTAT Activation in Brown Norway Rats.
J Pharmacol Exp Ther
; 370(2): 137-147, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31085698
13.
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Acta Neuropathol
; 138(2): 237-250, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31131421
14.
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid ß burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.
Alzheimers Dement
; 14(5): 634-643, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29156223
15.
A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response.
Pharmacol Res
; 99: 116-24, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26051661
16.
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.
Mol Neurodegener
; 19(1): 1, 2024 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38172904
17.
Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment.
Front Neurosci
; 17: 1221401, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37746151
18.
Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer's disease in individuals with mild cognitive impairment: The NORFACE cohort.
Front Neurosci
; 17: 1076177, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36908784
19.
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress.
Sci Rep
; 13(1): 5406, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012306
20.
Pyrazine-based Syk kinase inhibitors.
Bioorg Med Chem Lett
; 22(8): 2784-8, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22425453